reference/9995532

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9995532

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	384
issn	1476-5462 0969-7128
issueIdentifier	4
pageRange	375-384
publicationName	Gene Therapy
startingPage	375
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7a55ed715359c972a891ed509ec910f2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bbf3f1680ba26f911363defdf646d53 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63a10cdc60b7d3dd86bb19c7c26ac3c0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_123935ddddab1766a5c91aaf15c3fc63 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c9361ccd47d547d8a8c5ef9f3338fde5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a429478282e96d4cb3579fa545742a8a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e5bd7ba9f8a063f0aef394b59b32566a
bibliographicCitation	Cheng B, Ling C, Dai Y, Lu Y, Glushakova LG, Gee SW, McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, Siemann D, Liu C, Srivastava A, Ling C. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther. 2012 Apr;19(4):375–84. PMID: 21776025; PMCID: PMC3519243.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50e465ea182d3f2c94ca820d8cd0484b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65bd5f2eff72a4e617123a237aa09c33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef69c2f7c883aceaba11af64fc34aed8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c387dea2c4b1c4ccf70e229c1e39d439 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d9f75c07b1e39ea53f0bb3f2ce75be2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9eace1b70ca5c0a8fa4ff0ba65e0b66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26e1b15aa5c89d9c3685d3f9f1abf6a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12974060ba8e6535b68147d70d5e97ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f55faa99966a7c5b58c25dfa5c0cde16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ebc46a9a04ede4c1a95e009122cf62d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1254f51de8371a063fb49149571ffaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_663c5a99f6f28d88b38998fbd6864760 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d67c5434600cfbf735e98db765e4b49
date	2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/gt.2011.105 https://pubmed.ncbi.nlm.nih.gov/PMC3519243 https://pubmed.ncbi.nlm.nih.gov/21776025
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8603 https://portal.issn.org/resource/ISSN/0969-7128 https://portal.issn.org/resource/ISSN/1476-5462
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
discusses	http://id.nlm.nih.gov/mesh/M0022203 http://id.nlm.nih.gov/mesh/M0029482 http://id.nlm.nih.gov/mesh/M0560885
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601 http://purl.org/au-research/vocabulary/anzsrc-for/2008/06
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c4c4909eaa4fc41a39f0fa5c96f30cd6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 58.